Trending Stock News

As Fossil Group (FOSL) Stock Value Declined, Holder Contrarius Investment Management LTD Lifted Stake; Mairs & Power Trimmed Its Holding in Bio (TECH) by $540,840 as Valuation Rose

Contrarius Investment Management Ltd increased its stake in Fossil Group Inc (FOSL) by 511.84% based on its latest 2017Q3 regulatory filing with the SEC. Contrarius Investment Management Ltd bought 929,803 shares as the company’s stock declined 40.42% while stock markets rallied. The institutional investor held 1.11 million shares of the consumer non-durables company at the end of 2017Q3, valued at $10.37 million, up from 181,660 at the end of the previous reported quarter. Contrarius Investment Management Ltd who had been investing in Fossil Group Inc for a number of months, seems to be bullish on the $749.89 million market cap company. The stock decreased 8.94% or $1.52 during the last trading session, reaching $15.45. About 4.95M shares traded or 83.55% up from the average. Fossil Group, Inc. (NASDAQ:FOSL) has declined 54.09% since February 15, 2017 and is downtrending. It has underperformed by 70.79% the S&P500.

Mairs & Power Inc decreased its stake in Bio (TECH) by 0.31% based on its latest 2017Q3 regulatory filing with the SEC. Mairs & Power Inc sold 4,507 shares as the company’s stock rose 4.48% with the market. The institutional investor held 1.44M shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $174.62M, down from 1.45 million at the end of the previous reported quarter. Mairs & Power Inc who had been investing in Bio for a number of months, seems to be less bullish one the $5.27B market cap company. The stock decreased 0.01% or $0.01 during the last trading session, reaching $140.73. About 29,830 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 6.75% since February 15, 2017 and is uptrending. It has underperformed by 9.95% the S&P500.

Investors sentiment decreased to 1.21 in Q3 2017. Its down 0.23, from 1.44 in 2017Q2. It worsened, as 16 investors sold TECH shares while 86 reduced holdings. 36 funds opened positions while 87 raised stakes. 35.91 million shares or 2.04% less from 36.66 million shares in 2017Q2 were reported. Opus Point Management Ltd Liability Corporation holds 0.46% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH) for 4,268 shares. Nuveen Asset Mgmt Limited Liability holds 0% in Bio-Techne Corporation (NASDAQ:TECH) or 1,983 shares. Pnc Financial Svcs Grp Inc reported 55,567 shares. Atlanta Co L L C reported 1.95M shares. Cornerstone Advsrs stated it has 5 shares or 0% of all its holdings. 55,031 are owned by Credit Agricole S A. Cambridge Inv Rech reported 0.01% in Bio-Techne Corporation (NASDAQ:TECH). Parametrica Mngmt Ltd has invested 0.16% in Bio-Techne Corporation (NASDAQ:TECH). Schroder Group Inc has invested 0.07% in Bio-Techne Corporation (NASDAQ:TECH). Hightower Advsr Ltd Liability Com holds 0% or 1,755 shares. Lpl Fincl Ltd Llc has invested 0% in Bio-Techne Corporation (NASDAQ:TECH). Macquarie Gp Limited reported 0.04% stake. The Switzerland-based Swiss Bancshares has invested 0.01% in Bio-Techne Corporation (NASDAQ:TECH). Qs Ltd Com has 0% invested in Bio-Techne Corporation (NASDAQ:TECH). Sit Invest reported 7,225 shares stake.

Among 9 analysts covering BIO-TECHNE Corp (NASDAQ:TECH), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. BIO-TECHNE Corp had 22 analyst reports since August 18, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, February 9 by Citigroup. On Thursday, January 18 the stock rating was maintained by Robert W. Baird with “Buy”. As per Tuesday, February 6, the company rating was maintained by Robert W. Baird. The stock has “Neutral” rating by Janney Capital on Monday, March 27. The firm earned “Buy” rating on Tuesday, December 5 by Leerink Swann. The rating was maintained by Robert W. Baird on Monday, October 23 with “Buy”. Zacks upgraded Bio-Techne Corporation (NASDAQ:TECH) on Tuesday, September 1 to “Sell” rating. The company was maintained on Tuesday, October 31 by Robert W. Baird. The rating was maintained by Stephens on Wednesday, February 7 with “Hold”. The company was maintained on Wednesday, August 9 by Deutsche Bank.

Mairs & Power Inc, which manages about $7.72B and $8.33B US Long portfolio, upped its stake in Procter & Gamble (NYSE:PG) by 6,541 shares to 338,829 shares, valued at $30.83M in 2017Q3, according to the filing. It also increased its holding in Ishares Msci Eafe Fd (EFA) by 5,600 shares in the quarter, for a total of 12,539 shares, and has risen its stake in Tile Shop Inc (NASDAQ:TTS).

Since September 6, 2017, it had 0 buys, and 3 selling transactions for $153,199 activity. HOLBROOK KAREN A also sold $128,909 worth of Bio-Techne Corporation (NASDAQ:TECH) shares.

Contrarius Investment Management Ltd, which manages about $1.71 billion US Long portfolio, decreased its stake in Kinross Gold Corp (NYSE:KGC) by 420,886 shares to 15.79 million shares, valued at $66.96 million in 2017Q3, according to the filing. It also reduced its holding in Arch Coal Inc by 159,177 shares in the quarter, leaving it with 629,953 shares, and cut its stake in Iamgold Corp (NYSE:IAG).

Leave a Reply

Your email address will not be published. Required fields are marked *